Rigel Pharmaceuticals Inc... (RIGL)
22.34
-0.72 (-3.12%)
At close: Mar 03, 2025, 3:59 PM
22.59
1.12%
After-hours: Mar 03, 2025, 04:00 PM EST
Rigel Pharmaceuticals Income Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 | FY06 | FY05 | FY04 | FY03 | FY02 | FY01 | FY00 | FY99 |
| Revenue | 116.88M | 120.24M | 149.24M | 108.62M | 59.29M | 44.51M | 4.48M | 20.38M | 28.89M | 8.25M | 7.15M | 2.25M | 4.75M | 125M | 750K | n/a | 12.6M | 33.47M | 16.53M | 4.73M | 11.05M | 15.79M | 15.3M | 13.22M | 8.98M |
| Cost of Revenue | 7.11M | 1.75M | 1.08M | 895K | 906K | 287K | 46.27M | 63.45M | 62.83M | 67.7M | 75.33M | 78.78M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -7.56M | -1.91M |
| Gross Profit | 109.77M | 118.49M | 148.15M | 107.73M | 58.38M | 44.22M | -41.78M | -43.06M | -33.93M | -59.45M | -68.18M | -76.53M | 4.75M | 125M | 750K | n/a | 12.6M | 33.47M | 16.53M | 4.73M | 11.05M | 15.79M | 15.3M | 20.77M | 10.89M |
| Operating Income | -20.49M | -54.23M | -8.97M | -28.97M | -69.09M | -72.68M | -79.62M | -69.74M | -51.74M | -91.25M | -89.47M | -99.38M | -86.37M | 35.32M | -112.04M | -136.71M | -79.53M | -43.05M | -47.92M | -56.87M | -40.83M | -37.02M | -24.96M | -25.5M | -12.08M |
| Interest Income | 2.27M | 684K | 47K | 582K | 2.53M | 2.2M | 892K | 437K | 222K | 243K | 442K | 537K | 420K | 303K | 600K | 4.44M | 5.48M | 5.7M | 2.94M | 966K | 374K | 856K | 1.96M | 1.08M | n/a |
| Pretax Income | -25.09M | -58.57M | -17.31M | -29.74M | -66.89M | -70.48M | -77.99M | -69.22M | -51.46M | -90.91M | -89.03M | -98.84M | -85.97M | 37.89M | -111.64M | -132.44M | -74.27M | -37.64M | -45.26M | -56.26M | -41.2M | -37.03M | -23.8M | -25.36M | n/a |
| Net Income | -25.09M | -61.6M | -17.91M | -30.39M | -66.55M | -70.48M | -77.99M | -69.22M | -51.46M | -90.91M | -89.03M | -98.84M | -85.97M | 37.89M | -111.55M | -132.35M | -74.27M | -37.64M | -45.26M | -56.26M | -41.2M | -37.03M | -23.8M | -25.36M | -12.37M |
| Selling & General & Admin | 105.74M | 112.45M | 91.89M | 76.6M | 74.59M | 70M | 37.83M | 20.91M | 17.81M | 31.8M | 19.61M | 22.85M | 21.77M | 25.29M | 20.9M | 27.04M | 21.76M | 19.55M | 12.41M | 13.08M | 8.52M | 9.45M | 7.95M | 6.69M | 3.95M |
| Research & Development | 24.52M | 60.27M | 65.24M | 60.1M | 52.88M | 46.9M | 46.27M | 63.45M | 62.83M | 67.7M | 75.33M | 78.78M | 69.35M | 64.39M | 90.74M | 109.67M | 70.36M | 56.97M | 52.04M | 48.52M | 43.36M | 43.35M | 32.31M | 32.03M | 17.11M |
| Other Expenses | n/a | 1.32M | 3.52M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 7.56M | 1.91M |
| Operating Expenses | 130.26M | 172.72M | 157.13M | 136.7M | 127.47M | 116.91M | 84.1M | 84.35M | 80.64M | 99.5M | 94.94M | 101.63M | 91.12M | 89.68M | 111.65M | 136.71M | 92.13M | 76.52M | 64.45M | 61.6M | 51.88M | 52.8M | 40.26M | 46.28M | 22.97M |
| Interest Expense | 6.87M | 3.71M | 4.86M | 1.35M | 335K | n/a | n/a | n/a | n/a | n/a | 16K | 17K | 25K | 91K | 203K | 160K | 221K | 290K | 276K | 324K | 575K | 870K | 802K | 933K | n/a |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 137.37M | 174.47M | 158.21M | 137.59M | 128.38M | 117.19M | 84.1M | 84.35M | 80.64M | 99.5M | 94.94M | 101.63M | 91.12M | 89.68M | 111.65M | 136.71M | 92.13M | 76.52M | 64.45M | 61.6M | 51.88M | 52.8M | 40.26M | 38.72M | 21.06M |
| Income Tax | n/a | 3.02M | 605K | 647K | -348K | 2.2M | -2.09M | 4.3M | -1.72M | -2.7M | n/a | -2.43M | 420K | 91K | -93K | -89K | n/a | n/a | n/a | -612K | 370K | n/a | n/a | n/a | 286K |
| Shares Outstanding (Basic) | 17.4M | 17.24M | 17.05M | 16.88M | 16.72M | 16.05M | 12.63M | 9.44M | 8.84M | 8.77M | 8.73M | 74.88M | 63.33M | 52.05M | 40.88M | 36.02M | 28.94M | 24.94M | 21.86M | 18.05M | 11.39M | 554.94K | 4.14M | 806.92K | 34.79K |
| Shares Outstanding (Diluted) | 17.4M | 17.24M | 17.05M | 16.88M | 16.74M | 16.05M | 12.63M | 9.44M | 8.84M | 8.77M | 8.73M | 74.97M | 63.33M | 52.57M | 40.88M | 36.02M | 28.94M | 24.94M | 21.86M | 18.05M | 11.39M | 554.94K | 4.14M | 806.92K | 34.79K |
| EPS (Basic) | -1.44 | -3.4 | -1.05 | -1.76 | -4 | -4.39 | -6.17 | -7.33 | -5.82 | -10.37 | -10.2 | -1.32 | -1.36 | 0.73 | -2.73 | -3.67 | -2.57 | -1.51 | -2.07 | -3.12 | -3.62 | -66.73 | -5.75 | -31.43 | -355.49 |
| EPS (Diluted) | -1.44 | -3.4 | -1.05 | -1.76 | -4 | -4.39 | -6.17 | -7.33 | -5.82 | -10.37 | -10.2 | -1.32 | -1.36 | 0.72 | -2.73 | -3.67 | -2.57 | -1.51 | -2.07 | -3.12 | -3.62 | -66.73 | -5.75 | -31.43 | -355.49 |
| EBITDA | -16.98M | -53.87M | -11.29M | -27.68M | -65.88M | -69.89M | -77.53M | -63.03M | -50.3M | -88.89M | -85.2M | -96.94M | -83.99M | 39.3M | -110.03M | -130.85M | -79.53M | -43.05M | -47.92M | -54.49M | -37.65M | -31.19M | -18.2M | -17.95M | -10.17M |
| Depreciation & Amortization | 1.24M | 998K | 1.16M | 706K | 683K | 594K | 465K | 941K | 1.44M | 2.36M | 2.59M | 2.43M | 1.96M | 1.32M | 1.4M | 1.43M | 1.34M | 1.42M | 1.18M | 2.37M | 3.18M | 5.82M | 6.76M | 7.56M | 1.91M |